Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unison Nutraceuticals Sdn. Bhd. is a GMP-certified Malaysian manufacturer specializing in OTC pharmaceuticals, health/nutritional supplements, complementary medicines, and shelf-stable probiotics for private label, OEM, and contract manufacturing partners. Their capabilities include GMP and ISO 17025:2017-certified facilities, functional food (HACCP) lines, and dedicated Halal production, but no public evidence of drug R&D, clinical trial pipeline, biotech platforms, or classic pharma drug discovery activity[1]. Their primary offering is commercial-scale manufacturing for brand owners, not proprietary therapies, thus no defined clinical pipeline, targets, or modalities typical of a drug-development biotechnology firm. Their core markets are general wellness, probiotics, and food/nutrition supplements for pharmacies and health stores, with global export focus. No public stock symbol, key people, or major partnerships readily identified[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unison Nutraceuticals.